J Korean Med Sci.  2022 Jul;37(28):e232. 10.3346/jkms.2022.37.e232.

Time to Care for Adrenal Insufficiency in Cancer Patients

• Kim JH

• KMID: 2531805
• DOI: http://doi.org/10.3346/jkms.2022.37.e232

Reference

1. Kwon MK, Kim J, Ahn J, Woo CY, Kim H, Oh HS, et al. Clinical features and risk factors of adrenal insufficiency in patients with cancer admitted to the hospitalist-managed medical unit. J Korean Med Sci. 2022; 37(28):e222.

2. Han HS, Park JC, Park SY, Lee KT, Bae SB, Kim HJ, et al. A prospective multicenter study evaluating secondary adrenal suppression after antiemetic dexamethasone therapy in cancer patients receiving chemotherapy: a Korean south west oncology group study. Oncologist. 2015; 20(12):1432–1439. PMID: 26463869.

3. Mann M, Koller E, Murgo A, Malozowski S, Bacsanyi J, Leinung M. Glucocorticoidlike activity of megestrol. A summary of Food and Drug Administration experience and a review of the literature. Arch Intern Med. 1997; 157(15):1651–1656. PMID: 9250225.

4. Hahner S, Ross RJ, Arlt W, Bancos I, Burger-Stritt S, Torpy DJ, et al. Adrenal insufficiency. Nat Rev Dis Primers. 2021; 7(1):19. PMID: 33707469.

5. Prete A, Bancos I. Glucocorticoid induced adrenal insufficiency. BMJ. 2021; 374(1380):n1380. PMID: 34253540.